Ventas/$VTR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ventas
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Ticker
$VTR
Sector
Primary listing
NYSE
Industry
Health Care REITs
Headquarters
Employees
498
ISIN
US92276F1003
Website
Ventas Metrics
BasicAdvanced
$30B
200.91
$0.33
0.97
$1.86
2.92%
Price and volume
Market cap
$30B
Beta
0.97
52-week high
$71.36
52-week low
$52.79
Average daily volume
3.5M
Dividend rate
$1.86
Financial strength
Current ratio
0.629
Quick ratio
0.148
Long term debt to equity
108.897
Total debt to equity
108.897
Dividend payout ratio (TTM)
531.50%
Interest coverage (TTM)
1.28%
Profitability
EBITDA (TTM)
1,928.465
Gross margin (TTM)
42.14%
Net profit margin (TTM)
2.82%
Operating margin (TTM)
15.29%
Effective tax rate (TTM)
-43.62%
Revenue per employee (TTM)
$10,150,000
Management effectiveness
Return on assets (TTM)
1.91%
Return on equity (TTM)
1.38%
Valuation
Price to earnings (TTM)
200.915
Price to revenue (TTM)
5.482
Price to book
2.59
Price to tangible book (TTM)
2.85
Price to free cash flow (TTM)
25.335
Free cash flow yield (TTM)
3.95%
Free cash flow per share (TTM)
259.72%
Dividend yield (TTM)
2.83%
Forward dividend yield
2.92%
Growth
Revenue change (TTM)
9.48%
Earnings per share change (TTM)
-281.01%
3-year revenue growth (CAGR)
8.84%
10-year revenue growth (CAGR)
5.94%
3-year earnings per share growth (CAGR)
-4.22%
10-year earnings per share growth (CAGR)
-14.44%
3-year dividend per share growth (CAGR)
0.55%
10-year dividend per share growth (CAGR)
-4.92%
What the Analysts think about Ventas
Analyst ratings (Buy, Hold, Sell) for Ventas stock.
Bulls say / Bears say
Ventas reported a 13.2% year-over-year increase in revenue for Q1 2025, reaching $1.36 billion, surpassing analyst expectations of $1.32 billion. (reuters.com)
The company secured new lease agreements with Kindred Healthcare and its parent companies for 23 long-term acute care hospitals, enhancing its healthcare portfolio. (investing.com)
Analysts have shown confidence in Ventas, with Deutsche Bank upgrading its price target to $70 from $55, maintaining a Buy rating. (investing.com)
Ventas announced a public offering of 10.6 million shares, potentially diluting existing shareholders' value. (investing.com)
The company reported a net income of $46.87 million in Q1 2025, which, while positive, may not meet some investors' expectations for higher profitability. (reuters.com)
Wells Fargo & Company reduced its stock position in Ventas, indicating potential concerns about the company's future performance. (marketbeat.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
Ventas Financial Performance
Revenues and expenses
Ventas Earnings Performance
Company profitability
Ventas News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ventas stock?
Ventas (VTR) has a market cap of $30B as of July 21, 2025.
What is the P/E ratio for Ventas stock?
The price to earnings (P/E) ratio for Ventas (VTR) stock is 200.91 as of July 21, 2025.
Does Ventas stock pay dividends?
Yes, the Ventas (VTR) stock pays dividends to shareholders. As of July 21, 2025, the dividend rate is $1.86 and the yield is 2.92%. Ventas has a payout ratio of 531.5% on a trailing twelve-month basis.
When is the next Ventas dividend payment date?
The next Ventas (VTR) dividend payment date is unconfirmed.
What is the beta indicator for Ventas?
Ventas (VTR) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.